Perrigo Company plc
Moat Score — Perrigo Company plc
Total Moat Score
14 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Owns recognizable branded OTC products (Opill, Mederma, Compeed, ellaOne, Jungle Formula) but the large majority of revenue is unbranded store-brand manufacturing with no IP differentiation. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 4 / 5 | Large-scale OTC manufacturing footprint across the Americas and Europe gives real unit-cost advantages versus smaller private-label competitors, which is the core of the store-brand value proposition. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Store-brand pricing is set largely by retailer customers seeking a discount to national brands; FY2025 saw sales declines and a large goodwill impairment, evidence of limited pricing leverage. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | No network effects; consumer product manufacturing does not become more valuable as more users adopt it. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Retail private-label contracts create some switching friction (qualification, supply agreements), but retailers can and do shift store-brand manufacturing to competitors. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | Significant manufacturing scale and breadth across OTC categories, though the market is large enough to support several big-scale competitors (Church & Dwight, Prestige Consumer Healthcare, private-label peers). |